Page last updated: 2024-10-23

benzbromarone and Diabetic Retinopathy

benzbromarone has been researched along with Diabetic Retinopathy in 1 studies

Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.

Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thounaojam, MC1
Montemari, A1
Powell, FL1
Malla, P1
Gutsaeva, DR1
Bachettoni, A1
Ripandelli, G1
Repossi, A1
Tawfik, A1
Martin, PM1
Facchiano, F1
Bartoli, M1

Other Studies

1 other study available for benzbromarone and Diabetic Retinopathy

ArticleYear
Monosodium Urate Contributes to Retinal Inflammation and Progression of Diabetic Retinopathy.
    Diabetes, 2019, Volume: 68, Issue:5

    Topics: Allopurinol; Animals; Benzbromarone; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Humans;

2019